Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

Maryza Graham1, Stephen Muhi2, Tuyet Hoang3

  • 1Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Microbiology and Infectious Diseases, Monash Health, Clayton, Vic, Australia.

Pathology
|September 25, 2021
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos